Flexion Therapeutics (FLXN) – Analyst Ratings
-
Northland Capital Markets Downgrades Flexion Therapeutics (FLXN) to Market Perform
-
UPDATE: H.C. Wainwright Downgrades Flexion Therapeutics (FLXN) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FLXN Stock Lookup